Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1985-12-02
1990-06-19
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
424 856, 424 857, 530351, 435 6951, A61K 4502, C07K 1526, C07K 1300, C12P 2100
Patent
active
049352334
ABSTRACT:
Described is a new class of polypeptide cell modulators characterized by being composed of two covalently linked cell modulators in a linear polypeptide sequence. Such dual function polypeptides have new and particularly useful activities when the component polypeptide cell modulators are interferons, lymphokines or cytotoxins which act through different and specific cell receptors to initiate complementary biological activities.
REFERENCES:
patent: 4468382 (1984-08-01), Bacha et al.
patent: 4691009 (1987-09-01), Palmer et al.
patent: 4734491 (1988-03-01), Caruther
patent: 4758428 (1988-07-01), Mark et al.
Shepard et al., Nature, vol. 294, pp. 563-565, 1981.
Bell Leslie D.
McCullagh Keith G.
Porter Alan G.
G. D. Searle and Company
Hazel Blondel
Kanady Mary Jo
Matukaitis Paul D.
LandOfFree
Covalently linked polypeptide cell modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Covalently linked polypeptide cell modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Covalently linked polypeptide cell modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2259360